1.
Patient and medication factors associated with preventable medication waste and possibilities for redispensing
2.
3.
4.
5.
Discrepancies Between Medical and Pharmacy Records for Patients on Anti-HIV Drugs
Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin
Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies
Effects of electronic communication between the GP and the pharmacist. The quality of medication data on admission and after discharge